In Vitro Toxicology Testing - Global Market Outlook (2017-2023) According to Stratistics MRC, the Global In Vitro Toxicology Testing Market is accounted for $14.13 billion in 2016 and is expected to reach $37.27 billion by 2023 growing at a CAGR of 14.8% during the forecast period. Factors such as technological advancements and increasing government funding are fueling the market growth. However, strict regulations and predictive ability of in vitro testing over in vivo testing are hampering the market. Growing drug discovery and innovation in the market provides ample of opportunities for players in the market. By technology, cell culture technologies segment is anticipated to occupy the largest share. During the process of inhaling the human lungs may get exposed to toxic particles from the air which damages the respiratory system. With the help of cell culture technologies one can identify the risk associated with the toxic particles and the risk can balanced against other benefits. On the basis of region, North America is forecasted to occupy largest share due to the presence of large players in this region that offers In Vitro technology. Also, stringent regulations regarding the animal usage in toxicity analysis contribute towards high requirement of in-vitro tests in
In Vitro Toxicology Testing - Global Market Outlook (2017-2023)
↧
↧
Global 3D Cell Culture Market - Segmented by Technology, Application and End-User - Growth, Trends and Forecasts (2018 - 2023)
Global 3D Cell Culture Market - Segmented by Technology, Application and End-User - Growth, Trends and Forecasts (2018 - 2023) The global 3D Cell Culture market has been estimated to reach USD 682.8 million in 2017. The market is expected to register a CAGR of 20.3% during the forecast period, 2018 to 2023. North America dominates the market due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries. Rising Need for Organ Transplantation Cell culture is a process to grow prokaryotic cells or eukaryotic cells artificially, outside their natural environment, in a laboratory under controlled conditions. During the last decade, the demand for organ transplantation has increased, worldwide, due to increased incidences of organ failure, rise in success and improvement in post-transplant outcome. Increasing healthcare costs, aging population and rising prevalence of chronic disease that will continue to shape the industrial life science and thus majority of life science companies are investing in R&D sector. Additionally, development of automated large-scale cell culture systems, use of 3D cell culture models, as an alternative tool in vivo testing and increasing focus on the regenerative medicine is also acting as a driver for Global 3D Cell Culture Market. Budget Restriction for
↧
More Pages to Explore .....
